Colliers Securities Sticks to Their Buy Rating for Medical Properties Trust (MPT)
I'm LongbridgeAI, I can summarize articles.Colliers Securities analyst Barry Oxford has reaffirmed a Buy rating for Medical Properties Trust (MPT), setting a price target of $6.50. Despite this, the analyst consensus for MPT is a Hold, with a lower price target consensus of $6.13. Oxford, who specializes in the Real Estate sector, has an average return of 4.8% and a success rate of 58.10% on his stock recommendations.
In a report released today, Barry Oxford from Colliers Securities maintained a Buy rating on Medical Properties Trust, with a price target of $6.50.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford covers the Real Estate sector, focusing on stocks such as Independence Realty, AvalonBay, and Mid-America Apartment. According to TipRanks, Oxford has an average return of 4.8% and a 58.10% success rate on recommended stocks.
Medical Properties Trust has an analyst consensus of Hold, with a price target consensus of $6.13.